These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 8264861

  • 1. Inhibitory effect of a highly potent antagonist of LH releasing hormone (SB-75) on the pituitary gonadal axis in the intact and castrated rat.
    Ayalon D, Farhi Y, Comaru-Schally AM, Schally AV, Eckstein N, Vagman I, Limor R.
    Neuroendocrinology; 1993 Aug; 58(2):153-9. PubMed ID: 8264861
    [Abstract] [Full Text] [Related]

  • 2. Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75).
    Bokser L, Srkalovic G, Szepeshazi K, Schally AV.
    Neuroendocrinology; 1991 Aug; 54(2):136-45. PubMed ID: 1662786
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the in vitro and in vivo activity of the L-, D,L- and D-Cit6 forms of the LH-RH antagonist Cetrorelix (SB-75).
    Pinski J, Schally AV, Yano T, Groot K, Srkalovic G, Serfozo P, Reissmann T, Bernd M, Deger W, Kutscher B.
    Int J Pept Protein Res; 1995 May; 45(5):410-7. PubMed ID: 7591480
    [Abstract] [Full Text] [Related]

  • 4. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
    Campen CA, Lai MT, Kraft P, Kirchner T, Phillips A, Hahn DW, Rivier J.
    Biochem Pharmacol; 1995 May 11; 49(9):1313-21. PubMed ID: 7763313
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of biological activities of new LH-RH antagonists (T-series) in male and female rats.
    Pinski J, Yano T, Janaky T, Nagy A, Juhasz A, Bokser L, Groot K, Schally AV.
    Int J Pept Protein Res; 1993 Jan 11; 41(1):66-73. PubMed ID: 8436447
    [Abstract] [Full Text] [Related]

  • 6. Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
    Szende B, Srkalovic G, Groot K, Lapis K, Schally AV.
    Cancer Res; 1990 Jun 15; 50(12):3716-21. PubMed ID: 2160323
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.
    Yano T, Pinski J, Halmos G, Szepeshazi K, Groot K, Schally AV.
    Proc Natl Acad Sci U S A; 1994 Jul 19; 91(15):7090-4. PubMed ID: 7518926
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, Cetrorelix (SB-75).
    Gonzalez-Barcena D, Vadillo Buenfil M, Garcia Procel E, Guerra-Arguero L, Cardenas Cornejo I, Comaru-Schally AM, Schally AV.
    Eur J Endocrinol; 1994 Sep 19; 131(3):286-92. PubMed ID: 7921214
    [Abstract] [Full Text] [Related]

  • 9. Sustained release formulations of luteinizing hormone-releasing hormone antagonist SB-75 inhibit proliferation and enhance apoptotic cell death of human prostate carcinoma (PC-82) in male nude mice.
    Redding TW, Schally AV, Radulovic S, Milovanovic S, Szepeshazi K, Isaacs JT.
    Cancer Res; 1992 May 01; 52(9):2538-44. PubMed ID: 1568223
    [Abstract] [Full Text] [Related]

  • 10. Diverse effects of a potent LH-RH antagonist on the LH and FSH release.
    Kovács M, Koppán M, Mezó I, Teplán I.
    Acta Biol Hung; 1994 May 01; 45(2-4):285-96. PubMed ID: 7725823
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone.
    Yano T, Pinski J, Radulovic S, Schally AV.
    Proc Natl Acad Sci U S A; 1994 Mar 01; 91(5):1701-5. PubMed ID: 8127868
    [Abstract] [Full Text] [Related]

  • 12. Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75.
    Szende B, Srkalovic G, Groot K, Lapis K, Schally AV.
    J Natl Cancer Inst; 1990 Mar 21; 82(6):513-7. PubMed ID: 2156080
    [Abstract] [Full Text] [Related]

  • 13. Effect of recombinant inhibin on gonadotropin secretion during proestrus and estrus in the rat.
    Rivier C, Schwall R, Mason A, Burton L, Vale W.
    Endocrinology; 1991 May 21; 128(5):2223-8. PubMed ID: 1902163
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH.
    Yano T, Korkut E, Pinski J, Szepeshazi K, Milovanovic S, Groot K, Clarke R, Comaru-Schally AM, Schally AV.
    Breast Cancer Res Treat; 1992 May 21; 21(1):35-45. PubMed ID: 1391973
    [Abstract] [Full Text] [Related]

  • 15. Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models.
    Roth C, Hegemann F, Hildebrandt J, Balzer I, Witt A, Wuttke W, Jarry H.
    Pediatr Res; 2004 Jan 21; 55(1):126-33. PubMed ID: 14605254
    [Abstract] [Full Text] [Related]

  • 16. Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-stimulating hormone-releasing effect in rats.
    Kovacs M, Seprodi J, Koppan M, Horvath JE, Vincze B, Teplan I, Flerko B.
    J Neuroendocrinol; 2002 Aug 21; 14(8):647-55. PubMed ID: 12153467
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the pituitary-gonadal axis in nude male mice by continuous administration of LHRH agonists and antagonists.
    Redding TW, Schally AV.
    J Endocrinol; 1990 Aug 21; 126(2):309-15. PubMed ID: 2144873
    [Abstract] [Full Text] [Related]

  • 18. Induction of the gonadotrophin surge-inhibiting factor by FSH and its elimination: a sex difference in the efficacy of the priming effect of gonadotrophin-releasing hormone on the rat pituitary gland.
    Koppenaal DW, van Dieten JA, Tijssen AM, de Koning J.
    J Endocrinol; 1993 Aug 21; 138(2):191-201. PubMed ID: 8228727
    [Abstract] [Full Text] [Related]

  • 19. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J, Lamharzi N, Halmos G, Groot K, Jungwirth A, Vadillo-Buenfil M, Kakar SS, Schally AV.
    Endocrinology; 1996 Aug 21; 137(8):3430-6. PubMed ID: 8754771
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
    Radulovic S, Comaru-Schally AM, Milovanovic S, Schally AV.
    Pancreas; 1993 Jan 21; 8(1):88-97. PubMed ID: 8093555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.